Back

News Releases

  1. News Releases

News Releases

News Releases

May 10, 2021
Providing patients with genetic testing designed to accelerate the diagnosis and personalized treatment of Parkinson’s disease (PD) The Rostock International Parkinson's Disease (ROPAD) Study aims to characterize the genetics of PD to establish a better understanding of disease progression,
May 6, 2021
CENTOGENE’s rare disease mutation database offers new features and previously unpublished variants Database has grown to more than 465,000 analyzed patients, with more than 225,000 being linked to HPO terms Release includes increase of almost 19 million to over 31 million unique variants New
April 14, 2021
CAMBRIDGE, Mass., ROSTOCK, Germany and BERLIN, April 14, 2021 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical